Mastercard: COVID-19 Therapeutics Accelerator Awards $20 Million in Initial Grants to Fund Clinical Trials
March 31, 2020
March 31, 2020
PURCHASE, New York, March 31 -- Mastercard issued the following news release on March 30:
The partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions--the University of Washington, University of Oxford, and La Jolla Institute for Immunology--to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic. These grants mark the first investments to come from the COVID-19 Therapeutics Accelerator, a l . . .
The partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions--the University of Washington, University of Oxford, and La Jolla Institute for Immunology--to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic. These grants mark the first investments to come from the COVID-19 Therapeutics Accelerator, a l . . .